{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T14:58:26Z","timestamp":1648825106023},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10165-011-0543-3","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T05:13:54Z","timestamp":1319174034000},"page":"483-487","source":"Crossref","is-referenced-by-count":1,"title":["Leukocytapheresis (LCAP) for treating refractory adult-onset Still\u2019s disease (AOSD)"],"prefix":"10.1093","volume":"22","author":[{"given":"Yasumori","family":"Izumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadayoshi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiichiro","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Ezaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,10,22]]},"reference":[{"key":"543_CR1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","volume":"70","author":"J Pouchot","year":"1991","unstructured":"Pouchot J, Sampalis JS, Beaudet F, Carette S, D\u00e9cary F, Salusinsky-Sternbach M, et al. Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients. Medicine. 1991;70:118\u201336.","journal-title":"Medicine"},{"key":"543_CR2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.2005.042143","volume":"65","author":"P Efthimiou","year":"2006","unstructured":"Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still\u2019s disease. Ann Rheum Dis. 2006;65:564\u201372.","journal-title":"Ann Rheum Dis"},{"key":"543_CR3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","volume":"22","author":"B Fautrel","year":"2008","unstructured":"Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol. 2008;22:773\u201392.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"543_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MD.0b013e3181caf100","volume":"89","author":"A Hot","year":"2010","unstructured":"Hot A, Toh ML, Copp\u00e9r\u00e9 B, Perard L, Madoux MH, Mausservey C, et al. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case\u2013control study of 8 patients. Medicine. 2010;89:37\u201346.","journal-title":"Medicine"},{"key":"543_CR5","first-page":"1425","volume":"19","author":"M Coffernils","year":"1992","unstructured":"Coffernils M, Soupart A, Pradier O, Feremans W, N\u00e8ve P, Decaux G. Hyperferritinemia in adult onset Still\u2019s disease and the hemophagocytic syndrome. J Rheumatol. 1992;19:1425\u20137.","journal-title":"J Rheumatol"},{"key":"543_CR6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ncprheum0510","volume":"3","author":"P Efthimiou","year":"2007","unstructured":"Efthimiou P, Kontzias A, Ward CM, Ogden NS. Adult-onset Still\u2019s disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nat Clin Pract Rheumatol. 2007;3:328\u201335.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"543_CR7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/ard.2004.024026","volume":"64","author":"B Fautrel","year":"2005","unstructured":"Fautrel B, Sibilia J, Mariette X, Combe B, Club Rhumatismes et Inflammation. Tumour necrosis factor alpha blocking agents in refractory adult Still\u2019s disease: an observational study of 20 cases. Ann Rheum Dis. 2005;64:262\u20136.","journal-title":"Ann Rheum Dis"},{"key":"543_CR8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/1529-0131(199904)42:3<431::AID-ANR6>3.0.CO;2-2","volume":"42","author":"T Hidaka","year":"1999","unstructured":"Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Kataharada K, Ishizuka T, et al. Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 1999;42:431\u20137.","journal-title":"Arthritis Rheum"},{"key":"543_CR9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10165-005-0448-0","volume":"16","author":"Y Izumi","year":"2006","unstructured":"Izumi Y, Tominaga M, Iwanaga N, Huang M, Tanaka F, Aratake K, et al. Twenty-four-week follow-up examination of a leukocytapheresis therapy in rheumatoid arthritis. Mod Rheumatol. 2006;16:20\u20133.","journal-title":"Mod Rheumatol"},{"key":"543_CR10","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992;19:424\u201330.","journal-title":"J Rheumatol"},{"key":"543_CR11","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2005.046904","volume":"65","author":"JB Arlet","year":"2006","unstructured":"Arlet JB, Le TH, Marinho A, Amoura Z, Wechsler B, Papo T, et al. Reactive haemophagocytic syndrome in adult-onset Still\u2019s disease: a report of six patients and a review of the literature. Ann Rheum Dis. 2006;65:1596\u2013601.","journal-title":"Ann Rheum Dis"},{"key":"543_CR12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3899\/jrheum.101269","volume":"38","author":"NM Wulffraat","year":"2011","unstructured":"Wulffraat NM. Defining criteria for macrophage activation syndrome, a process towards early recognition and treatment. J Rheumatol. 2011;38:593\u20134.","journal-title":"J Rheumatol"},{"key":"543_CR13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.bor.0000381996.69261.71","volume":"22","author":"AA Grom","year":"2010","unstructured":"Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol. 2010;22:561\u20136.","journal-title":"Curr Opin Rheumatol"},{"key":"543_CR14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3899\/jrheum.100996","volume":"38","author":"S Dav\u00ec","year":"2011","unstructured":"Dav\u00ec S, Consolaro A, Guseinova D, Pistorio A, Ruperto N, Martini A, et al. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2011;38:764\u20138.","journal-title":"J Rheumatol"},{"key":"543_CR15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00000441-200309000-00009","volume":"326","author":"K Omagari","year":"2003","unstructured":"Omagari K, Matsunaga Y, Yamashita H, Nishiyama H, Hazama H, Oda H, et al. Successful treatment with cyclosporin in adult-onset Still disease manifesting as acute hepatitis with marked hyperferritinemia. Am J Med Sci. 2003;326:148\u201351.","journal-title":"Am J Med Sci"},{"key":"543_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semarthrit.2007.04.002","volume":"37","author":"I K\u00f6tter","year":"2007","unstructured":"K\u00f6tter I, Wacker A, Koch S, Henes J, Richter C, Engel A, et al. Anakinra in patients with treatment-resistant adult-onset Still\u2019s disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum. 2007;37:189\u201397.","journal-title":"Semin Arthritis Rheum"},{"key":"543_CR17","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/art.21061","volume":"52","author":"AA Fitzgerald","year":"2005","unstructured":"Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA. Rapid responses to anakinra in patients with refractory adult-onset Still\u2019s disease. Arthritis Rheum. 2005;52:1794\u2013803.","journal-title":"Arthritis Rheum"},{"key":"543_CR18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","volume":"67","author":"T Lequerr\u00e9","year":"2008","unstructured":"Lequerr\u00e9 T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, Soci\u00e9t\u00e9 Francophone pour la Rhumatologie et les Maladies Inflammatoires en P\u00e9diatrie (SOFREMIP), Club Rhumatismes et Inflammation (CRI), et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis. 2008;67:302\u20138.","journal-title":"Ann Rheum Dis"},{"key":"543_CR19","first-page":"141","volume":"28","author":"M Yoshimura","year":"2010","unstructured":"Yoshimura M, Makiyama J, Koga T, Miyashita T, Izumi Y, Torigoshi T, et al. Successful treatment with tocilizumab in a patient with refractory adult-onset Still\u2019s disease (AOSD). Clin Exp Rheumatol. 2010;28:141\u20132.","journal-title":"Clin Exp Rheumatol"},{"key":"543_CR20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10165-010-0348-9","volume":"21","author":"M Kobayashi","year":"2011","unstructured":"Kobayashi M, Takahashi Y, Yamashita H, Kaneko H, Mimori A. Benefit and a possible risk of tocilizumab therapy for adult-onset Still\u2019s disease accompanied by macrophage-activation syndrome. Mod Rheumatol. 2011;21:92\u20136.","journal-title":"Mod Rheumatol"},{"key":"543_CR21","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1172\/JCI116307","volume":"91","author":"G Hahn","year":"1993","unstructured":"Hahn G, Stuhlm\u00fcller B, Hain N, Kalden JR, Pfizenmaier K, Burmester GR. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy. J Clin Invest. 1993;91:862\u201370.","journal-title":"J Clin Invest"},{"key":"543_CR22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jca.1016","volume":"16","author":"T Hidaka","year":"2001","unstructured":"Hidaka T, Suzuki K, Kawakami M, Okada M, Kataharada K, Shinohara T, et al. Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. J Clin Apher. 2001;16:74\u201381.","journal-title":"J Clin Apher"},{"key":"543_CR23","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/s00535-004-1464-0","volume":"39","author":"A Andoh","year":"2004","unstructured":"Andoh A, Ogawa A, Kitamura K, Inatomi O, Fujino S, Tsujikawa T, et al. Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis. J Gastroenterol. 2004;39:1150\u20137.","journal-title":"J Gastroenterol"},{"key":"543_CR24","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s10067-006-0256-8","volume":"26","author":"H Tanaka","year":"2007","unstructured":"Tanaka H, Tsugawa K, Nakahata T, Suzuki K, Ito E. Leukocytapheresis for the treatment of refractory systemic-onset juvenile idiopathic arthritis. Clin Rheumatol. 2007;26:1014\u20136.","journal-title":"Clin Rheumatol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0543-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:26Z","timestamp":1646843126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0543-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,22]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["543"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0543-3","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,22]]}}}